Review
The xenotropic murine leukemia virus-related retrovirus debate continues at first international workshop
-
* Corresponding author: Stuart FJ Le Grice legrices@mail.nih.gov
1 MRC National Institute for Medical Research, The Ridgeway, Mill Hill, London NW71AA, UK
2 Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA
3 Department of Virology, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands
4 HIV Drug Resistance Program, National Cancer Institute, Frederick, MD 21702, USA
Retrovirology 2010, 7:113 doi:10.1186/1742-4690-7-113
Published: 22 December 2010Abstract
The 1st International Workshop on Xenotropic Murine Leukemia Virus-Related Retrovirus (XMRV), co-sponsored by the National Institutes of Health, The Department of Health and Human Services and Abbott Diagnostics, was convened on September 7/8, 2010 on the NIH campus, Bethesda, MD. Attracting an international audience of over 200 participants, the 2-day event combined a series of plenary talks with updates on different aspects of XMRV research, addressing basic gammaretrovirus biology, host response, association of XMRV with chronic fatigue syndrome and prostate cancer, assay development and epidemiology. The current status of XMRV research, concerns among the scientific community and suggestions for future actions are summarized in this meeting report.